This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Dec;4(12):650-1.

doi: 10.1038/ncpuro0965. Epub 2007 Oct 23.

What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy?

Robert E Reiter¹, Stephen Riggs

Affiliations

PMID: 17955047
DOI: 10.1038/ncpuro0965

Comment

What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy?

Robert E Reiter et al. Nat Clin Pract Urol. 2007 Dec.

. 2007 Dec;4(12):650-1.

doi: 10.1038/ncpuro0965. Epub 2007 Oct 23.

Authors

Robert E Reiter¹, Stephen Riggs

Affiliation

¹ Department of Urology, Prostate Cancer at the University of California, Los Angeles, CA 90095, USA. rreiter@mednet.ucla.edu

PMID: 17955047
DOI: 10.1038/ncpuro0965

No abstract available

PubMed Disclaimer

Comment on

Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-33. doi: 10.1016/j.ijrobp.2006.08.056. Epub 2006 Nov 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17084558

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal